Joann Vennari
Genentech
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joann Vennari.
The Journal of Infectious Diseases | 1997
Phillip W. Berman; Alane Gray; Terri Wrin; Joann Vennari; Donna J. Eastman; Gerald R. Nakamura; Donald P. Francis; Geoffrey J. Gorse; David H. Schwartz
Proviral sequences were determined and immunologic characterization was carried out for envelope glycoproteins from 7 vaccinees who became infected with human immunodeficiency virus type 1 (HIV-1), through high-risk behavior, while participating in clinical trials of MN-rgp120, a candidate HIV-1 vaccine. All 7 infections resulted from subtype B viruses; however, only 3 of the viruses possessed the MN serotype-defining V3 domain sequence, IGPGRAF, prevalent in 60%-70% of US infections. Six of the 7 viruses differed from MN-rgp120 at a neutralizing epitope in the C4 domain, and all 7 differed from MN-rgp120 at a neutralizing epitope in the V2 domain. Recombinant gp120 was prepared from each breakthrough specimen and tested for binding to a panel of neutralizing monoclonal antibodies. The results suggest that 6 of 7 breakthrough infections may be related to incomplete immunization or to infection with viruses that differed from the vaccine immunogen at important virus-neutralizing epitopes.
Biotechnology Progress | 2000
Shengjiang Liu; Mark Carroll; Raquel Iverson; Christine Valera; Joann Vennari; Kimberly Turco; Robert Piper; Robert Kiss; Herbert Lutz
Commercial bioreactors employing mammalian cell cultures to express biological or pharmaceutical products can become contaminated with adventitious viruses. The high expense of such a contamination can be reduced by passing all gases and fluids feeding the bioreactor through virus inactivation or removal steps, which act as viral barriers around the bioreactor. A novel virus barrier filter has been developed for removing viruses from serum‐free cell culture media. This filter removes the 20 nm minute virus of mice by >3 log reduction value (LRV), the 28 nm bacteriophage ΦX174 by >4.5 LRV, the mycoplasma Acholeplasma laidlawii by ≥8.8 LRV, and the bacteria Brevundimonas diminuta by ≥9.2 LRV. Robust removal occurs primarily by size exclusion as demonstrated over a wide range of feedstocks and operating conditions. The filtered media are indistinguishable from unfiltered media in growth of cells to high densities, maintenance of cell viability, and productivity in expressing protein product. Insulin and transferrin show high passage through the filter. The virus barrier filter can be autoclaved. The relatively high membrane permeability enables the use of a moderate filtration area.
Journal of Virology | 1995
Terri Wrin; Tatjana P. Loh; Joann Vennari; Hanneke Schuitemaker; Jack H. Nunberg
The Journal of Infectious Diseases | 1996
Phillip W. Berman; Krishna K. Murthy; Terri Wrin; Joann Vennari; E. Kathy Cobb; Donna J. Eastman; Mark Champe; Gerald R. Nakamura; Donna Davison; Michael F. Powell; Jeanine Bussiere; Donald P. Francis; Thomas J. Matthews; Timothy Gregory; John F. Obijeski
AIDS Research and Human Retroviruses | 1994
Jeffrey L. Cleland; Michael F. Powell; Amy Lim; Barrón L; Phillip W. Berman; Donna J. Eastman; Jack H. Nunberg; Terri Wrin; Joann Vennari
The Journal of Allergy and Clinical Immunology | 2001
Daniel Tumas; Betty Chan; Winifred Werther; Terri Wrin; Joann Vennari; Noelyn Desjardin; Robert L. Shields; Paula M. Jardieu
Journal of Pharmaceutical Sciences | 1998
Jeffrey L. Cleland; Amy Lim; Ann L. Daugherty; Lorena Barrón; Noelyn Desjardin; Eileen T. Duenas; Donna J. Eastman; Joann Vennari; Terri Wrin; Phillip W. Berman; Krishna K. Murthy; Michael F. Powell
Journal of Pharmaceutical Sciences | 1996
Jeffrey L. Cleland; Lorena Barrón; Phillip W. Berman; Ann L. Daugherty; Tim Gregory; Amy Lim; Joann Vennari; Terri Wrin; Michael F. Powell
Journal of Pharmaceutical Sciences | 1996
Jeffrey L. Cleland; Lorena Barrón; Ann L. Daugherty; Donna J. Eastman; Charlotte R. Kensil; Amy Lim; Robert P. Weissburg; Terri Wrin; Joann Vennari; Michael F. Powell
Biologicals | 2002
Dejin Zhan; Margaret R. Roy; Christine Valera; Jesse Cardenas; Joann Vennari; Janice W. Chen; Shengjiang Liu